Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · May 08, 2023

ARVO 2023: Enzyme Replacement Treatment May Slow Retinal Thinning With CLN2-Type Batten Disease

Safety, effectiveness shown in first intravitreal enzyme replacement research in humans

PracticeUpdate Editorial Team

 

Further Reading